Visco Tablet Uses

Rating: 5 - 2 review(s)
How times a day do you take this medicine?
sponsored

What is Visco Tablet?

Visco Tablet is used as a dietary supplement for individuals who are deficient in Visco Tablet. Although a balanced diet usually supplies all the Visco Tablet a person needs, Visco Tablet supplements may be needed by patients who have lost Visco Tablet because of illness or treatment with certain medicines.

Lack of Visco Tablet may lead to irritability, muscle weakness, and irregular heartbeat.

Injectable Visco Tablet is given only by or under the supervision of a health care professional. Some oral Visco Tablet preparations are available only with a prescription. Others are available without a prescription.

Visco Tablet indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

peptic ulcer, gastritis, dyspepsia

How should I use Visco Tablet?

Use Visco Tablet as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Visco Tablet.

Uses of Visco Tablet in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.

This medication is a mineral supplement used to prevent and treat low amounts of Visco Tablet in the blood. Visco Tablet is very important for the normal functioning of cells, nerves, muscles, bones, and the heart. Usually, a well-balanced diet provides normal blood levels of Visco Tablet. However, certain situations cause your body to lose Visco Tablet faster than you can replace it from your diet. These situations include treatment with "water pills" (diuretics such as furosemide, hydrochlorothiazide), a poor diet, alcoholism, or other medical conditions (e.g., severe diarrhea/vomiting, stomach/intestinal absorption problems, poorly controlled diabetes).

How to use Visco Tablet (oxide/AA chelate)

Take this product by mouth as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.

It is best to take Visco Tablet supplements with a meal to reduce stomach upset and diarrhea unless otherwise directed by the product instructions or your doctor.

Take each dose with a full glass (8 ounces or 240 milliliters) of water unless your doctor directs you otherwise. Swallow extended-release capsules and delayed-release/enteric coated tablets or capsules whole. Do not crush or chew extended-release or delayed-release/enteric coated capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.

If you are using a liquid product, use a medication measuring device to carefully measure the dose. Do not use a household spoon because you may not get the correct dose. If you are using a suspension, shake the bottle well before each dose.

Take this medication regularly in order to get the most benefit from it. Remember to take it at the same time(s) each day. Dosage is based on your medical condition and response to treatment. Do not increase your dose or take it more often than directed on the product package or by your doctor. Too much Visco Tablet in the blood can cause serious side effects.

Tell your doctor if symptoms of low Visco Tablet blood levels (e.g., muscle cramps, tiredness, irritability, depression) persist or worsen. If you think you may have a serious medical problem, seek immediate medical attention.

Visco Tablet dosage

sponsored

Usual Adult Dose for Hypomagnesemia

500 to 1000 mg Visco Tablet gluconate (27 to 54 mg elemental Visco Tablet) orally 3 times a day.

Usual Adult Dose for Dietary Supplement

500 to 1000 mg Visco Tablet gluconate (27 to 54 mg elemental Visco Tablet) orally once a day.

Usual Pediatric Dose for Hypomagnesemia

10 to 20 mg/kg of elemental Visco Tablet per dose orally 4 times a day. Use Visco Tablet gluconate oral liquid preparations for more accurate measurement of dose.

Renal Dose Adjustments

Do not use without physician supervision in patients with renal impairment due to increased risk of hypermagnesemia. The use of Visco Tablet salts are generally contraindicated in patients with severe renal dysfunction.

Liver Dose Adjustments

Data not available

Dose Adjustments

May increase by 500 to 1,000 mg/day (27 to 54 mg elemental Visco Tablet) in order to achieve a normal serum Visco Tablet level. Daily doses > 1,000 mg (54 mg elemental Visco Tablet) should be given in 2 to 3 divided doses.

Precautions

Because Visco Tablet is primarily eliminated by the kidney, there is significant risk of hypermagnesemia in patients with renal dysfunction.

Dialysis

Data not available; however, use of Visco Tablet salts is generally contraindicated in renal failure.

Other Comments

Visco Tablet supplements are often used with "low normal" serum Visco Tablet levels in patients predisposed to hypomagnesemia (e.g., patients on diuretics).

Visco Tablet interactions

See also:
What other drugs will affect Visco Tablet?

sponsored

Alfacalcidol: May increase the serum concentration of Visco Tablet Salts. Consider therapy modification

Alpha-Lipoic Acid: Visco Tablet Salts may decrease the absorption of Alpha-Lipoic Acid. Alpha-Lipoic Acid may decrease the absorption of Visco Tablet Salts. Consider therapy modification

Baloxavir Marboxil: Polyvalent Cation Containing Products may decrease the serum concentration of Baloxavir Marboxil. Avoid combination

Bictegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Bictegravir. Management: Administer bictegravir under fasting conditions at least 2 hours before or 6 hours after polyvalent cation containing products. Coadministration of bictegravir with or 2 hours after most polyvalent cation products is not recommended. Consider therapy modification

Bisphosphonate Derivatives: Polyvalent Cation Containing Products may decrease the serum concentration of Bisphosphonate Derivatives. Management: Avoid administration of oral medications containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate. Exceptions: Pamidronate; Zoledronic Acid. Consider therapy modification

Calcitriol (Systemic): May increase the serum concentration of Visco Tablet Salts. Management: Consider using a non-Visco Tablet-containing antacid or phosphate-binding product in patients also receiving calcitriol. If Visco Tablet-containing products must be used with calcitriol, serum Visco Tablet concentrations should be monitored closely. Consider therapy modification

Calcium Channel Blockers: May enhance the adverse/toxic effect of Visco Tablet Salts. Visco Tablet Salts may enhance the hypotensive effect of Calcium Channel Blockers. Monitor therapy

Deferiprone: Polyvalent Cation Containing Products may decrease the serum concentration of Deferiprone. Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours. Consider therapy modification

Dolutegravir: Visco Tablet Salts may decrease the serum concentration of Dolutegravir. Management: Administer dolutegravir at least 2 hours before or 6 hours after oral Visco Tablet salts. Administer the dolutegravir/rilpivirine combination product at least 4 hours before or 6 hours after oral Visco Tablet salts. Consider therapy modification

Doxercalciferol: May enhance the hypermagnesemic effect of Visco Tablet Salts. Management: Consider using a non-Visco Tablet-containing antacid or phosphate-binding product in patients also receiving doxercalciferol. If Visco Tablet-containing products must be used with doxercalciferol, serum Visco Tablet concentrations should be monitored closely. Consider therapy modification

Eltrombopag: Polyvalent Cation Containing Products may decrease the serum concentration of Eltrombopag. Management: Administer eltrombopag at least 2 hours before or 4 hours after oral administration of any polyvalent cation containing product. Consider therapy modification

Elvitegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Elvitegravir. Management: Administer elvitegravir 2 hours before or 6 hours after the administration of polyvalent cation containing products. Consider therapy modification

Gabapentin: Visco Tablet Salts may enhance the CNS depressant effect of Gabapentin. Specifically, high dose intravenous/epidural Visco Tablet sulfate may enhance the CNS depressant effects of gabapentin. Visco Tablet Salts may decrease the serum concentration of Gabapentin. Management: Administer gabapentin at least 2 hours after use of a Visco Tablet-containing antacid. Monitor patients closely for evidence of reduced response to gabapentin therapy. Monitor for CNS depression if high dose IV/epidural Visco Tablet sulfate is used. Consider therapy modification

Levothyroxine: Visco Tablet Salts may decrease the serum concentration of Levothyroxine. Management: Separate administration of oral levothyroxine and oral Visco Tablet salts by at least 4 hours. Consider therapy modification

Multivitamins/Fluoride (with ADE): Visco Tablet Salts may decrease the serum concentration of Multivitamins/Fluoride (with ADE). Specifically, Visco Tablet salts may decrease fluoride absorption. Management: To avoid this potential interaction separate the administration of Visco Tablet salts from administration of a fluoride-containing product by at least 1 hour. Consider therapy modification

Mycophenolate: Visco Tablet Salts may decrease the serum concentration of Mycophenolate. Management: Separate doses of mycophenolate and oral Visco Tablet salts. Monitor for reduced effects of mycophenolate if taken concomitant with oral Visco Tablet salts. Consider therapy modification

Neuromuscular-Blocking Agents: Visco Tablet Salts may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. Monitor therapy

PenicillAMINE: Polyvalent Cation Containing Products may decrease the serum concentration of PenicillAMINE. Management: Separate the administration of penicillamine and oral polyvalent cation containing products by at least 1 hour. Consider therapy modification

Phosphate Supplements: Visco Tablet Salts may decrease the serum concentration of Phosphate Supplements. Management: Administer oral phosphate supplements as far apart from the administration of an oral Visco Tablet salt as possible to minimize the significance of this interaction. Exceptions: Sodium Glycerophosphate Pentahydrate. Consider therapy modification

Quinolones: Visco Tablet Salts may decrease the serum concentration of Quinolones. Management: Administer oral quinolones several hours before (4 h for moxi/pe/spar-, 2 h for others) or after (8 h for moxi-, 6 h for cipro/dela-, 4 h for lome/pe-, 3 h for gemi-, and 2 h for levo-, nor-, or ofloxacin or nalidixic acid) oral Visco Tablet salts. Exceptions: LevoFLOXacin (Oral Inhalation). Consider therapy modification

Raltegravir: Visco Tablet Salts may decrease the serum concentration of Raltegravir. Management: Avoid the use of oral / enteral Visco Tablet salts with raltegravir. No dose separation schedule has been established that adequately reduces the magnitude of interaction. Avoid combination

Tetracyclines: Visco Tablet Salts may decrease the absorption of Tetracyclines. Only applicable to oral preparations of each agent. Management: Avoid coadministration of oral Visco Tablet salts and oral tetracyclines. If coadministration cannot be avoided, administer oral Visco Tablet at least 2 hours before, or 4 hours after, oral tetracyclines. Monitor for decreased tetracycline therapeutic effects. Exceptions: Eravacycline. Consider therapy modification

Trientine: Polyvalent Cation Containing Products may decrease the serum concentration of Trientine. Management: Avoid concomitant administration of trientine and oral products that contain polyvalent cations. If oral iron supplements are required, separate the administration by 2 hours. If other oral polyvalent cations are needed, separate administration by 1 hour. Consider therapy modification

Visco Tablet side effects

See also:
What are the possible side effects of Visco Tablet?

sponsored

Diarrhoea and bowel discomfort, due to the release of carbon dioxide caused by both Visco Tablet carbonate and sodium bicarbonate.

Excessive administration of Visco Tablet leads to the development of hypermagnesaemia, especially in renal insufficiency. Symptoms of hypermagnesaemia may include flushing of the skin, thirst, hypotension due to peripheral vasodilation, drowsiness, confusion, loss of tendon reflexes due to neuromuscular blockade, muscle weakness, respiratory depression, cardiac arrhythmias, coma, and cardiac arrest. Visco Tablet carbonate and Visco Tablet trisilicate may interfere with the absorption of other medicines when taken concomitantly. Administration of sodium bicarbonate by mouth can cause stomach cramps and flatulence.

Excessive administration of sodium bicarbonate may lead to metabolic alkalosis, especially in patients with impaired renal function. Symptoms may include shortness of breath, muscle weakness (associated with potassium depletion), and mental disturbances such as restlessness, convulsions, and coma. Muscle hypertonicity, twitching, and tetany may develop especially in hypocalcaemic patients due to increased protein binding and renal reabsorption of calcium. Excessive doses may also lead to sodium overloading and hyperosmolality. Sodium excess may result in hypernatraemia, a rise in extracellular concentration or in too much sodium and water in the body without change in extracellular concentration.

Retention of sodium leads to the accumulation of extracellular fluid (oedema) which may affect the cerebral, pulmonary or peripheral circulations.

Visco Tablet contraindications

See also:
What is the most important information I should know about Visco Tablet?

Sensitivity to any of the ingredients; patients with renal impairment and acute dehydration.

Active ingredient matches for Visco Tablet:

Magnesium Hydroxide (Milk of Magnesia)

Alginic Acid/Aluminium Hydroxide/Magnesium/Simethicone


Unit description / dosage (Manufacturer)Price, USD
Visco Tablet$ 0.01
VISCO TABLET 1 strip / 10 tablets each (Aristo Pharmaceuticals Pvt Ltd)$ 0.10

List of Visco Tablet substitutes (brand and generic names):

Gastromax O 170 ml Suspension (Elder Pharmaceuticals Ltd.)$ 0.03
Gelpec MPS 170 ml Gel (Modern Pharmaceuticals)$ 0.02
Geltec Gel 170 ml Syrup (Dutech Remedies (I) Pvt. Ltd.)$ 0.04
Gelucaine 170 ml Suspension (The Pharmed Research Lab Pvt Ltd)$ 0.03
Gigel 170 ml Gel (Prayas Pharmaceuticals)$ 0.01
HC Gel 200 ml Gel (Health Care Formulations Pvt. Ltd.)$ 0.02
HC Gel 100 ml Gel (Health Care Formulations Pvt. Ltd.)$ 0.02
HC REX 200 ml Gel (Health Care Formulations Pvt. Ltd.)$ 0.02
Hegel MPS Syrup (Health Guard (India) Pvt. Ltd.)$ 0.02
Hydralgel MPS 250+250+50 Tablet (Adcco Limited.)$ 0.01
Icycool 200 ml Syrup (Injecto Capta Pvt. Ltd.)$ 0.02
Inlicid MPS 170 ml Suspension (Indian Drugs and Pharmaceuticals Ltd (Ind Biosciences))$ 0.02
Intacid MPS 170 ml Syrup (Intas Laboratories Pvt Ltd)$ 0.05
Intacid MPS 60 ml Syrup (Intas Laboratories Pvt Ltd)$ 0.06
Intacid MPS Tablet (Intas Laboratories Pvt Ltd)$ 0.01
Neutrogel 170 ml Suspension (Beckcem Drugs International (P) Ltd)$ 0.02
Nokcid MPS 170 ml Syrup (Ambition Pharma Pvt. Ltd.)$ 0.02
Nomorcid MPS 170 ml Suspension (Acto Pharmaceuticals Laboratories)$ 0.02
Normacid 170 ml Gel (Saga Laboratories)$ 0.04
Nucid Gel 170 ml Nuclear Pharma Syrup (Nuclear Pharmaceuticals)$ 0.02
Nucid Gel 170 ml Suspension (Nuclear Pharmaceuticals)$ 0.00
Oltacal Tablet (Altar Healthcare (P) Ltd.)$ 0.04
Orcid 170 ml Suspension (Oirpil Biotech)$ 0.02
Oxecain Gel 200 ml Suspension (Saksham Pharmaceuticals (India) Limited)$ 0.03
Oxycane 170 ml Gel (Invision Medi Sciences)$ 0.05
Sanzyme DS Tablet (Uni-Sankyo Ltd.)$ 0.01
Silocid MPS 170 ml Suspension (Suzikem Drugs Pvt. Ltd.)$ 0.02
Simeco Gel 200 ml Gel (Wyeth Ltd.)$ 0.01
Stgel Mint 170 ml Suspension (ST Sharda Lifesciences)$ 0.06
Stomacid MPS 170 ml Syrup (Pramukh Swami Pharma Ltd.)$ 0.02
Sugel 200 ml Syrup (Winsun Laboratories)$ 0.05
Synogel 100 ml Gel (Synokem Pharmaceuticals Ltd)$ 0.03
Ticid 200 ml Suspension (Tunic Healthcare)$ 0.01
Tisbi 170 ml Syrup (Proteger India)$ 0.04
UD Alusil 200+300+25 Tablet (Union Drug Company Ltd)$ 0.00
Ulcid Tablet (Acron Pharmaceuticals)$ 0.01
Veecain 170 ml Syrup (Vsaar Pharma)$ 0.03
VISCO ORAL GEL 1 bottle / 170 ML oral gel each (Aristo Pharmaceuticals Pvt Ltd)$ 0.65
Zancid 170 ml Suspension (Jarson Pharmaceuticals)$ 0.02
Zocid Gel 170 ml Gel (Zota Healthcare Pvt. Ltd.)$ 0.02

References

  1. PubChem. "Simethicone". https://pubchem.ncbi.nlm.nih.gov/sub... (accessed September 17, 2018).
  2. DrugBank. "Simethicone - DrugBank". http://www.drugbank.ca/drugs/DB09512 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Visco Tablet are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Visco Tablet. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

1 consumer reported useful

Was the Visco Tablet drug useful in terms of decreasing the symptom or the disease?
According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
Users%
Useful1
100.0%


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


7 consumers reported age

Users%
30-454
57.1%
46-602
28.6%
16-291
14.3%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 8 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved